Impact of drug distribution into adipose on tissue function: The cholesteryl ester transfer protein (CETP) inhibitor anacetrapib as a test case

Abstract Anacetrapib is an inhibitor of cholesteryl ester transfer protein (CETP) previously under development as a lipid‐modifying agent that reduces LDL‐cholesterol and increases HDL‐cholesterol in hypercholesterolemic patients. Anacetrapib demonstrates a long terminal half‐life and accumulates in...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Douglas G. Johns, Sheng‐Ping Wang, Raymond Rosa, James Hubert, Suoyu Xu, Ying Chen, Thomas Bateman, Robert O. Blaustein
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Wiley 2019-12-01
Saila:	Pharmacology Research & Perspectives
Gaiak:	adipose anacetrapib cholesteryl ester transfer protein pharmacokinetics
Sarrera elektronikoa:	https://doi.org/10.1002/prp2.543
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!